Munzarová M, Kovarík J, Hlávková J, Kolcová V
Biomed Pharmacother. 1985;39(9-10):486-9.
The clinical records of 551 breast cancer patients were retrospectively analysed. Several parameters have been examined: age at presentation, distribution of stages at the time of diagnosis, incidence of any progression and "progression-free" interval after primary treatment, incidence of distant dissemination and distant metastasis-free interval, cancer mortality, time of survival from presentation and time of survival from detection of distant metastases (stage at presentation being taken into account in all evaluations). The results within various ABO blood groups were compared. There were no substantial differences in these parameters within different blood groups. The possible modifications of ABH (O) isoantigens on tumour cells and the immune response to these alien antigens is discussed.
对551例乳腺癌患者的临床记录进行了回顾性分析。研究了几个参数：就诊时的年龄、诊断时的分期分布、初次治疗后任何进展的发生率和“无进展”间期、远处转移的发生率和无远处转移间期、癌症死亡率、从就诊开始的生存时间和从发现远处转移开始的生存时间（在所有评估中均考虑就诊时的分期）。比较了不同ABO血型组的结果。不同血型组在这些参数上没有实质性差异。讨论了肿瘤细胞上ABH（O）同种抗原的可能修饰以及对这些外来抗原的免疫反应。
